Acadia Healthcare (ACHC)

• Market cap: $3.68B
• 1 day: -2.51%
• 5 days: -5.28%
• 1 month: -10.64%
• 3 months: 2.75%
• 6 months: -48.33%
• Year to date: -2.75%
• 1 year: -52.66%
• 5 years: 13.29%
• 10 years: -36.71%
• Sector: Healthcare
• Industry: Specialty Outpatient Facilities

About: Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

Employees: 23,500

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

680% more call options, than puts

Call options by funds: $92.7M | Put options by funds: $11.9M

75% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 7 (+3) [Q4]

26% more repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 89

0% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 75

1.25% less ownership

Funds ownership: 109.18% [Q3] → 107.93% (-1.25%) [Q4]

2% less funds holding

Funds holding: 306 [Q3] → 300 (-6) [Q4]

38% less capital invested

Capital invested by funds: $6.42B [Q3] → $3.98B (-$2.45B) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $43 8% upside
• Avg. target: $62 56% upside
• High target: $75 89% upside

6 analyst ratings

• positive: 5 83%
• neutral: 1 17%
• negative: 0 0%

RBC Capital Ben Hendrix 36% 1-year accuracy 24 / 67 met price target	61% upside $64	Outperform Reiterated	10 Jan 2025
TD Cowen Ryan Langston 10% 1-year accuracy 1 / 10 met price target	66% upside $66	Buy Maintained	7 Jan 2025
Keybanc Matthew Gillmor 31% 1-year accuracy 4 / 13 met price target	77% upside $70	Overweight Upgraded	7 Jan 2025
Deutsche Bank Pito Chickering 58% 1-year accuracy 7 / 12 met price target	89% upside $75	Buy Upgraded	12 Dec 2024
Cantor Fitzgerald Sarah James 31% 1-year accuracy 38 / 124 met price target	31% upside $52	Neutral Reiterated	10 Dec 2024